MARKET

TMBR

TMBR

Timber Pharmaceuticals
AMEX

Real-time Quotes | Nasdaq Last Sale

2.100
+0.460
+28.05%
Pre Market: 2.200 +0.1 +4.76% 05:36 02/25 EST
OPEN
1.760
PREV CLOSE
1.640
HIGH
2.330
LOW
1.736
VOLUME
1.08K
TURNOVER
--
52 WEEK HIGH
10.44
52 WEEK LOW
0.6651
MARKET CAP
25.27M
P/E (TTM)
-0.8077
1D
5D
1M
3M
1Y
5Y
News
Financial
Releases
Corp Actions
Analysis
Profile
FSR, SUNW, OSTK and DKL among midday movers
Gainers: Sypris Solutions (SYPR) +83%.9F (JFU) +39%.Owens & Minor (OMI) +38%.Sunworks (SUNW) +34%.R. R. Donnelley & Sons (RRD) +30%.Fisker (FSR) +28%.PubMatic (PUBM) +27%.dMY Technology (DMYI) +26%.Timber Pharmaceuticals (TMBR) +25%.Cancer Genetics (CGIX) ...
Seekingalpha · 17h ago
Onconova Therapeutics, Processa Pharmaceuticals leads healthcare gainers; Interpace Biosciences, AIkido Pharma among major losers
Gainers: Onconova Therapeutics (ONTX) +29%, Processa Pharmaceuticals (PCSA) +26%, AnPac Bio-Medical Science ANPC +25%, Oncolytics Biotech ONCY +22%, Cleveland BioLabs (CBLI) +15%.Losers: Interpace Biosciences IDXG -24%, AIkido Pharma AIKI -24%, Akers Biosc...
Seekingalpha · 02/17 15:57
SNDL, IMUX among premarket losers
Interpace Biosciences (IDXG) -28%. on Nasdaq delisting.Seanergy Maritime SHIP -23% on capital raise.KAR Auction Services KAR -22% on Q4 earnings.AIkido Pharma AIKI -20% on capital raise.Socket Mobile (SCKT) -20%.ALJ Regional (ALJJ) -17%.Immunic IMUX -17% d...
Seekingalpha · 02/17 13:39
43 Stocks Moving In Tuesday's Mid-Day Session
Gainers
Benzinga · 02/16 17:46
GTHX, KOPN, CAN and SESN among premarket gainers
Socket Mobile (SCKT) +181% after launching first enterprise-grade scanners for Apple iPhone 12 series.ALJ Regional Holdings (ALJJ) +71%.500.com Limited (WBAI) +74% after acquisition of crypto mining pool.Urban Tea, Inc. (MYT) +55%.Torchlight Energy Resourc...
Seekingalpha · 02/16 13:32
SNDL, OGI, MVIS and SONO among premarket gainers
AC Immune SA (ACIU) +112% as its vaccine generates potent anti-pTau antibody response in a phase 1b/2a study.RCM Technologies, Inc. (RCMT) +92%.Sundial Growers Inc. (SNDL) +48%.MicroVision, Inc. (MVIS) +44% after long range
Seekingalpha · 02/11 13:27
Sector Update: Health Care Stocks Ending Near Wednesday Session Lows
MT Newswires · 01/27 15:58
AMC, BB, BBBY and GME among notable premarket gainers
AMC Entertainment Holdings (AMC) +240%.Koss Corporation (KOSS) +117%.Express (EXPR) +91%.GameStop (GME) +55%.Vislink Technologies (VISL) +22% as shipping of Satellite communications equipment begins.Revlon (REV) +16%.J.Jill (JILL) +17%.Accelerate Diagnosti...
Seekingalpha · 01/27 13:26
More
Forecast
EPSBVPSCFPS
Actual (USD)
Estimate (USD)
Income StatementMore
Net IncomeTotal RevenueOperating Income
Net Income (USD)
YoY (%)
Balance SheetMore
Total Assets (USD)
Total Liabilities (USD)
Debt to Asset (%)
Cash FlowMore
OperatingInvestingFinancing
Operating (USD)
YoY (%)
Learn about the latest financial forecast of TMBR. Analyze the recent business situations of Timber Pharmaceuticals through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 1 analysts

Hold

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target
The average TMBR stock price target is 2.250 with a high estimate of 2.250 and a low estimate of 2.250.
EPS
Institutional Holdings
Institutions: 16
Institutional Holdings: 880.79K
% Owned: 7.32%
Shares Outstanding: 12.03M
TypeInstitutionsShares
Increased
5
172.81K
New
5
78.64K
Decreased
5
557.09K
Sold Out
7
10.38K
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Biotechnology & Medical Research
+1.05%
Pharmaceuticals & Medical Research
+1.12%
Key Executives
Chairman/Executive Director
Michael Derby
Chief Executive Officer/Director
John Koconis
Chief Financial Officer/Executive Vice President
Joseph Lucchese
Chief Operating Officer/Executive Vice President/Secretary/Director
Zachary Rome
Chief Accounting Officer
Joyce Goto
Other
Alan Mendelsohn
Director
Gianluca Pirozzi
Director
Edward Sitar
Independent Director
David Cohen
Independent Director
Lubor Gaal
  • Dividends
  • Splits
  • Insider Activity
No Data
About TMBR
Timber Pharmaceuticals, Inc., formerly BioPharmX Corporation, is a biopharmaceutical company. The Company is focused on the development and commercialization of treatments for orphan dermatologic diseases. It is developing treatments for rare dermatologic diseases including congenital ichthyosis (CI), tuberous sclerosis complex (TSC), and localized scleroderma. Its pipeline includes TMB-001, TMB-002 and TMB-003. TMB-001 is a topical isotretinoin, which is being developed for the treatment of moderate to severe subtypes of CI. TMB-002, a topical rapamycin, is being developed for the treatment of facial angiofibromas (FAs) in TSC. TMB-003 is a topical / subcutaneous ET-A receptor antagonist, which is being developed for localized scleroderma.

Webull offers kinds of Timber Pharmaceuticals Inc stock information, including AMEX:TMBR real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, TMBR stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading TMBR stock methods without spending real money on the virtual paper trading platform.